Lawmakers in the House of Representatives are considering a bill that
would add coverage of antianxiety medications to the Medicare prescription
drug benefit set to begin in January. The benefit currently excludes benzodiazepines
from coverage, which could put patients at risk and limit physicians’
Currently, all states provide some coverage for benzodiazepines for
low-income seniors under Medicaid; after the national prescription drug benefits
plan goes into effect, these individuals will be covered by Medicare and states
may eliminate coverage.
Kuehn BM. Antianxiety Inclusion. JAMA. 2005;294(6):673. doi:https://doi.org/10.1001/jama.294.6.673-c
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: